New eye drop aims to lower glaucoma pressure
NCT ID NCT07168902
First seen Jun 25, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This Phase 2 trial tests an experimental eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. Participants use the drops twice daily for 28 days. The study measures changes in vision and eye pressure to see if BL1107 is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BL1107 (experimental eye drop)
- What this could lead to
- If successful, BL1107 could offer a new option to help control eye pressure and protect vision in people with glaucoma.
- What could go wrong
- This is an early Phase 2 trial with only 252 participants over 28 days. The new eye drop may not work better than existing treatments, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
-
California Eye Specialist Medical Group, LLC
Pasadena, California, 91107, United States
-
Central Florida Eye Associates
Lakeland, Florida, 33805, United States
-
Clayton Eye Clinical Research, LLC
Morrow, Georgia, 30260, United States
-
Coastal Research Associates, LLC
Roswell, Georgia, 30076, United States
-
Eye Associates of Fort Myers
Fort Myers, Florida, 33901, United States
-
Eye Research Foundation
Newport Beach, California, 92663, United States
-
Global Research Management, Inc.
Glendale, California, 91204, United States
-
Heart of America Eye Care
Shawnee Mission, Kansas, 66204, United States
-
Houston Eye Associates
Houston, Texas, 77025, United States
-
Lee Shettle Eye and Hearing
Largo, Florida, 33773, United States
-
Levenson Eye Associates
Jacksonville, Florida, 32204, United States
-
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania, 16066, United States
-
Total Eye Care, P.A.
Memphis, Tennessee, 38119, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Which laser best tames glaucoma pressure?
- Could your personality predict glaucoma drug side effects?